Sinopsis
This volume looks at applications of artificial intelligence (AI), machine learning (ML), and deep learning (DL) in drug design. The chapters in this book describe how AI/ML/DL approaches can be applied to accelerate and revolutionize traditional drug design approaches such as: structure- and ligand-based, augmented and multi-objective de novo drug design, SAR and big data analysis, prediction of binding/activity, ADMET, pharmacokinetics and drug-target residence time, precision medicine and selection of favorable chemical synthetic routes. How broadly are these approaches applied and where do they maximally impact productivity today and potentially in the near future. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary software and tools, step-by-step, readily reproducible modeling protocols, and tips on troubleshooting and avoiding known pitfalls.
Cutting-edge and unique, Artificial Intelligence in Drug Design is a valuable resource for structural and molecular biologists, computational and medicinal chemists, pharmacologists and drug designers.
"Sinopsis" puede pertenecer a otra edición de este libro.
Acerca del autor
Charlotte y Peter Fiell son dos autoridades en historia, teoría y crítica del diseño y han escrito más de sesenta libros sobre la materia, muchos de los cuales se han convertido en éxitos de ventas. También han impartido conferencias y cursos como profesores invitados, han comisariado exposiciones y asesorado a fabricantes, museos, salas de subastas y grandes coleccionistas privados de todo el mundo. Los Fiell han escrito numerosos libros para TASCHEN, entre los que se incluyen 1000 Chairs, Diseño del siglo XX, El diseño industrial de la A a la Z, Scandinavian Design y Diseño del siglo XXI.
De la contraportada
This volume looks at applications of artificial intelligence (AI), machine learning (ML), and deep learning (DL) in drug design. The chapters in this book describe how AI/ML/DL approaches can be applied to accelerate and revolutionize traditional drug design approaches such as: structure- and ligand-based, augmented and multi-objective de novo drug design, SAR and big data analysis, prediction of binding/activity, ADMET, pharmacokinetics and drug-target residence time, precision medicine and selection of favorable chemical synthetic routes. How broadly are these approaches applied and where do they maximally impact productivity today and potentially in the near future. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary software and tools, step-by-step, readily reproducible modeling protocols, and tips on troubleshooting and avoiding known pitfalls.
Cutting-edge and unique, Artificial Intelligence in Drug Design is a valuable resource for structural and molecular biologists, computational and medicinal chemists, pharmacologists and drug designers.
"Sobre este título" puede pertenecer a otra edición de este libro.
Otras ediciones populares con el mismo título
Resultados de la búsqueda para Artificial Intelligence in Drug Design: 2390 (Methods...
Imagen de archivo
Artificial Intelligence in Drug Design (Methods in Molecular Biology, 2390)
Librería: HPB-Red, Dallas, TX, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
hardcover. Condición: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority! Nº de ref. del artículo: S_408540522
Comprar usado
EUR 175,62
Gastos de envío:
EUR 3,23
A Estados Unidos de America
Cantidad disponible: 1 disponibles
Imagen de archivo
Artificial Intelligence in Drug Design (Methods in Molecular Biology, 2390)
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Nº de ref. del artículo: ABLIING23Mar2317530223787
Comprar nuevo
EUR 232,86
Gastos de envío:
EUR 3,44
A Estados Unidos de America
Cantidad disponible: Más de 20 disponibles
Imagen del vendedor
Artificial Intelligence in Drug Design
Impresión bajo demandaLibrería: moluna, Greven, Alemania
Calificación del vendedor: 4 de 5 estrellas
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Includes cutting-edge techniquesProvides step-by-step detail essential for reproducible resultsContains key implementation advice from the expertsThis volume looks at applications of artificial intelligence (AI), machine lear. Nº de ref. del artículo: 471549477
Comprar nuevo
EUR 192,60
Gastos de envío:
EUR 48,99
De Alemania a Estados Unidos de America
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Artificial Intelligence in Drug Design (Methods in Molecular Biology, 2390)
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: New. In. Nº de ref. del artículo: ria9781071617861_new
Comprar nuevo
EUR 239,99
Gastos de envío:
EUR 13,67
De Reino Unido a Estados Unidos de America
Cantidad disponible: Más de 20 disponibles
Imagen del vendedor
Artificial Intelligence in Drug Design
Impresión bajo demandaLibrería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Calificación del vendedor: 5 de 5 estrellas
Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This volume looks at applications of artificial intelligence (AI), machine learning (ML), and deep learning (DL) in drug design. The chapters in this book describe how AI/ML/DL approaches can be applied to accelerate and revolutionize traditional drug design approaches such as: structure- and ligand-based, augmented and multi-objective de novo drug design, SAR and big data analysis, prediction of binding/activity, ADMET, pharmacokinetics and drug-target residence time, precision medicine and selection of favorable chemical synthetic routes. How broadly are these approaches applied and where do they maximally impact productivity today and potentially in the near future. Writtenin the highly successfulMethods in Molecular Biologyseries format, chapters include introductions to their respective topics, lists of the necessary software and tools, step-by-step, readily reproducible modeling protocols, and tips on troubleshooting and avoiding known pitfalls.Cutting-edge andunique,Artificial Intelligence in Drug Design is a valuable resource for structural and molecular biologists, computational and medicinal chemists, pharmacologists and drug designers. 544 pp. Englisch. Nº de ref. del artículo: 9781071617861
Comprar nuevo
EUR 235,39
Gastos de envío:
EUR 23,00
De Alemania a Estados Unidos de America
Cantidad disponible: 2 disponibles
Imagen del vendedor
Artificial Intelligence in Drug Design
Impresión bajo demandaLibrería: preigu, Osnabrück, Alemania
Calificación del vendedor: 5 de 5 estrellas
Buch. Condición: Neu. Artificial Intelligence in Drug Design | Alexander Heifetz | Buch | xi | Englisch | 2021 | Springer US | EAN 9781071617861 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. Nº de ref. del artículo: 120015173
Comprar nuevo
EUR 200,40
Gastos de envío:
EUR 70,00
De Alemania a Estados Unidos de America
Cantidad disponible: 5 disponibles
Imagen del vendedor
Artificial Intelligence in Drug Design
Publicado por
Springer US, Springer New York Nov 2021, 2021
ISBN 10: 1071617869
ISBN 13: 9781071617861
Nuevo
Tapa dura
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
Calificación del vendedor: 5 de 5 estrellas
Buch. Condición: Neu. Neuware -This volume looks at applications of artificial intelligence (AI), machine learning (ML), and deep learning (DL) in drug design. The chapters in this book describe how AI/ML/DL approaches can be applied to accelerate and revolutionize traditional drug design approaches such as: structure- and ligand-based, augmented and multi-objective de novo drug design, SAR and big data analysis, prediction of binding/activity, ADMET, pharmacokinetics and drug-target residence time, precision medicine and selection of favorable chemical synthetic routes. How broadly are these approaches applied and where do they maximally impact productivity today and potentially in the near future. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary software and tools, step-by-step, readily reproducible modeling protocols, and tips on troubleshooting and avoiding known pitfalls.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 544 pp. Englisch. Nº de ref. del artículo: 9781071617861
Comprar nuevo
EUR 235,39
Gastos de envío:
EUR 60,00
De Alemania a Estados Unidos de America
Cantidad disponible: 2 disponibles
Imagen de archivo
Artificial Intelligence in Drug Design
Publicado por
Springer (India) Private Limited, 2021
ISBN 10: 1071617869
ISBN 13: 9781071617861
Nuevo
Tapa dura
Librería: Books Puddle, New York, NY, Estados Unidos de America
Calificación del vendedor: 4 de 5 estrellas
Condición: New. pp. 529. Nº de ref. del artículo: 26389559259
Comprar nuevo
EUR 302,81
Gastos de envío:
EUR 3,44
A Estados Unidos de America
Cantidad disponible: 4 disponibles
Imagen del vendedor
Artificial Intelligence in Drug Design
Publicado por
Springer US, Springer New York, 2021
ISBN 10: 1071617869
ISBN 13: 9781071617861
Nuevo
Tapa dura
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Calificación del vendedor: 5 de 5 estrellas
Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume looks at applications of artificial intelligence (AI), machine learning (ML), and deep learning (DL) in drug design. The chapters in this book describe how AI/ML/DL approaches can be applied to accelerate and revolutionize traditional drug design approaches such as: structure- and ligand-based, augmented and multi-objective de novo drug design, SAR and big data analysis, prediction of binding/activity, ADMET, pharmacokinetics and drug-target residence time, precision medicine and selection of favorable chemical synthetic routes. How broadly are these approaches applied and where do they maximally impact productivity today and potentially in the near future. Writtenin the highly successfulMethods in Molecular Biologyseries format, chapters include introductions to their respective topics, lists of the necessary software and tools, step-by-step, readily reproducible modeling protocols, and tips on troubleshooting and avoiding known pitfalls.Cutting-edge andunique,Artificial Intelligence in Drug Design is a valuable resource for structural and molecular biologists, computational and medicinal chemists, pharmacologists and drug designers. Nº de ref. del artículo: 9781071617861
Comprar nuevo
EUR 240,56
Gastos de envío:
EUR 66,04
De Alemania a Estados Unidos de America
Cantidad disponible: 1 disponibles
Imagen de archivo
Artificial Intelligence in Drug Design
Publicado por
Springer (India) Private Limited, 2021
ISBN 10: 1071617869
ISBN 13: 9781071617861
Nuevo
Tapa dura
Librería: Majestic Books, Hounslow, Reino Unido
Calificación del vendedor: 4 de 5 estrellas
Condición: New. Print on Demand pp. 529 This item is printed on demand. Nº de ref. del artículo: 391089156
Comprar nuevo
EUR 324,73
Gastos de envío:
EUR 7,42
De Reino Unido a Estados Unidos de America
Cantidad disponible: 4 disponibles